HNRNPA1 and leukemia: Hence, heterogeneous nuclear ribonucleoprotein A1-mediated transfer of exosomal miR-320 from leukemia cells to BMSCs could be an important mediator of leukemia progression and a potential therapeutic target for chronic myelogenous leukemia.